Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

CRISPR Therapeutics AG - Common Shares (NQ:CRSP)

51.72 -0.54 (-1.03%)

Streaming Delayed Price Updated: 4:00 PM EDT, Sep 11, 2026 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	856,711
Open	52.35
Bid (Size)	51.57 (200)
Ask (Size)	51.87 (100)
Prev. Close	52.26
Today's Range	51.62 - 53.21
52wk Range	44.12 - 78.48
Shares Outstanding	78,935,098
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Amgen vs. CRISPR Therapeutics: Which Healthcare Stock Is a Better Buy in 2026? ↗

September 11, 2026

One company is generating billions in revenue and raising its dividend. The other is burning cash in pursuit of a scientific breakthrough that could change how diseases are treated.

Via The Motley Fool

Axsome Therapeutics vs. CRISPR Therapeutics: Which Healthcare Stock Is a Better Buy in 2026? ↗

September 11, 2026

One company is scaling revenue rapidly but burning cash; the other is pioneering gene therapy with minimal sales and massive losses.

Via The Motley Fool

Performance

YTD	-3.8%	-3.8%
1 Month	-4.2%	-4.2%
3 Month	-1.7%	-1.7%
6 Month	+6.8%	+6.8%
1 Year	-8.1%	-8.1%

More News

Set Yourself Up for a Strong 2027: 2 Pharmaceutical Stocks to Buy in September ↗

September 11, 2026

Via The Motley Fool

Why CRISPR Therapeutics Stock Rocked the Market Last Month ↗

September 08, 2026

Via The Motley Fool

Where Will CRISPR Therapeutics Stock Be in 5 Years? ↗

September 08, 2026

Via The Motley Fool

2 Reasons CRISPR Therapeutics Stock Could Soar in the Final 4 Months of 2026 ↗

September 02, 2026

Via The Motley Fool

CRISPR Therapeutics Stock Is Up Only 8% This Year. Is Cathie Wood's Bet on the Gene-Editing Stock Dead Money? ↗

August 21, 2026

Via The Motley Fool

Vertex Pharmaceuticals' Rally Has a New Engine -- and Wall Street Thinks the Best Is Still Ahead ↗

August 20, 2026

Via The Motley Fool

Morgan Stanley Nearly Doubled Its Price Target for CRISPR Therapeutics. Is the Gene-Editing Stock a No-Brainer Buy? ↗

July 30, 2026

Via The Motley Fool

3 Stocks With the Most Upside by the End of 2026 ↗

July 30, 2026

Via The Motley Fool

3 Mid-Cap Growth Stocks With Monstrous Long-Term Upside ↗

July 28, 2026

Via The Motley Fool

Cathie Wood's $362 Million CRISPR Therapeutics Bet Isn't Just Bold -- It's Backed by a Catalyst Many Investors Are Underrating ↗

July 22, 2026

Via The Motley Fool

Cathie Wood Is Buying This Up-and-Coming Biotech Stock. Should You Follow Her Lead? ↗

July 20, 2026

Via The Motley Fool

3 Reasons to Buy CRISPR Therapeutics Stock ↗

July 10, 2026

Via The Motley Fool

Vertex’s Crinetics Deal Balances Growth with Integration Risk ↗

July 08, 2026

Via MarketBeat

A New CRISPR "DNA Shredder" Could Change Gene-Editing -- What It Means for CRISPR Therapeutics ↗

July 08, 2026

Via The Motley Fool

Over 2 Billion Reasons to Love CRISPR Therapeutics Right Now ↗

July 07, 2026

Via The Motley Fool

CRISPR Therapeutics vs. Viking Therapeutics: Is a Gene-Editing or Weight Loss Focused Stock Is a Better Buy in 2026? ↗

July 07, 2026

Via The Motley Fool

CRISPR Therapeutics vs. Viking Therapeutics: Which Healthcare Stock Is a Better Buy in 2026? ↗

July 06, 2026

Via The Motley Fool

CRISPR Therapeutics AG vs. Vertex Pharmaceuticals: Which Healthcare Stock Is a Better Buy in 2026? ↗

June 27, 2026

Via The Motley Fool

The Best Stocks to Invest $1,000 in Right Now ↗

June 22, 2026

Via The Motley Fool

Why CRISPR Therapeutics Stock Has Been on a Roller-Coaster Ride This Year ↗

June 18, 2026

Via The Motley Fool

The Best Biotech Stocks to Buy in 2026 ↗

June 17, 2026

Via The Motley Fool

Here's How I'd Invest $10,000 Right Now ↗

June 17, 2026

Via The Motley Fool

CRISPR Therapeutics Has $2.4 Billion in Cash and an Approved Drug. Why Is Its Stock Trading Nearly 40% Below the Wall Street Consensus? ↗

June 08, 2026

Via The Motley Fool

Frequently Asked Questions

Is CRISPR Therapeutics AG - Common Shares publicly traded?

Yes, CRISPR Therapeutics AG - Common Shares is publicly traded.

What exchange does CRISPR Therapeutics AG - Common Shares trade on?

CRISPR Therapeutics AG - Common Shares trades on the Nasdaq Stock Market

What is the ticker symbol for CRISPR Therapeutics AG - Common Shares?

The ticker symbol for CRISPR Therapeutics AG - Common Shares is CRSP on the Nasdaq Stock Market

What is the current price of CRISPR Therapeutics AG - Common Shares?

The current price of CRISPR Therapeutics AG - Common Shares is 51.72

When was CRISPR Therapeutics AG - Common Shares last traded?

The last trade of CRISPR Therapeutics AG - Common Shares was at 09/11/26 04:00 PM ET

What is the market capitalization of CRISPR Therapeutics AG - Common Shares?

The market capitalization of CRISPR Therapeutics AG - Common Shares is 4.08B

How many shares of CRISPR Therapeutics AG - Common Shares are outstanding?

CRISPR Therapeutics AG - Common Shares has 4B shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.